#bimagrumab — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #bimagrumab, aggregated by home.social.
-
不想再挨針？「口服版瘦瘦筆」已送件FDA、新藥「哥吉拉」更號稱能減重 24%
julia 2025-11-18 13:55:00 CST
GLP-1減重藥物需求高漲，新一代藥物競出，不僅效果更強，亦有口服、長效劑型問世。未來幾年，隨著專利到期與市場競爭加劇，藥價可望降低，使更多患者受惠，2026年將成關鍵。
https://www.thenewslens.com/article/261249
#Ozempic #經濟學人 #GLP-1 #司美格魯肽 #三重促效劑 #MariTide #禮來公司 #醫療 #Wegovy #bimagrumab #瑞他魯肽注射劑 #體重管理 #專利到期 #瘦瘦針 #諾和諾德 #口服藥物 -
📈📉📈😩For those struggling with their weight and related health problems: Below I wrote up a thread about my brief experience so far with being prescribed the GLP1-agonist drugs #semaglutide (aka #Ozempic / #Wegovy) and #tirzepatide (aka #Mounjaro / #Zepbound), and my struggle to get insurance coverage (boo #FEPBlue! You suck!).
🧪🥼I also talk light science about a related experimental drug called #bimagrumab that I *might* be helping to test via a #ClinicalTrial. It's pretty fascinating stuff!
https://hachyderm.io/@mogul/114844234796648397 -
📈📉📈😩For those struggling with their weight and related health problems: Below I wrote up a thread about my brief experience so far with being prescribed the GLP1-agonist drugs #semaglutide (aka #Ozempic / #Wegovy) and #tirzepatide (aka #Mounjaro / #Zepbound), and my struggle to get insurance coverage (boo #FEPBlue! You suck!).
🧪🥼I also talk light science about a related experimental drug called #bimagrumab that I *might* be helping to test via a #ClinicalTrial. It's pretty fascinating stuff!
https://hachyderm.io/@mogul/114844234796648397 -
📈📉📈😩For those struggling with their weight and related health problems: Below I wrote up a thread about my brief experience so far with being prescribed the GLP1-agonist drugs #semaglutide (aka #Ozempic / #Wegovy) and #tirzepatide (aka #Mounjaro / #Zepbound), and my struggle to get insurance coverage (boo #FEPBlue! You suck!).
🧪🥼I also talk light science about a related experimental drug called #bimagrumab that I *might* be helping to test via a #ClinicalTrial. It's pretty fascinating stuff!
https://hachyderm.io/@mogul/114844234796648397 -
📈📉📈😩For those struggling with their weight and related health problems: Below I wrote up a thread about my brief experience so far with being prescribed the GLP1-agonist drugs #semaglutide (aka #Ozempic / #Wegovy) and #tirzepatide (aka #Mounjaro / #Zepbound), and my struggle to get insurance coverage (boo #FEPBlue! You suck!).
🧪🥼I also talk light science about a related experimental drug called #bimagrumab that I *might* be helping to test via a #ClinicalTrial. It's pretty fascinating stuff!
https://hachyderm.io/@mogul/114844234796648397 -
📈📉📈😩For those struggling with their weight and related health problems: Below I wrote up a thread about my brief experience so far with being prescribed the GLP1-agonist drugs #semaglutide (aka #Ozempic / #Wegovy) and #tirzepatide (aka #Mounjaro / #Zepbound), and my struggle to get insurance coverage (boo #FEPBlue! You suck!).
🧪🥼I also talk light science about a related experimental drug called #bimagrumab that I *might* be helping to test via a #ClinicalTrial. It's pretty fascinating stuff!
https://hachyderm.io/@mogul/114844234796648397 -
Expect a renewed big push for obesity treatments. Lots of money riding on these therapies!
Eli #Lilly will pay up to $1.9 billion to acquire biotech #Versanis for it’s Phase II #Obesity candidate #Bimagrumab, a #MonoclonalAntibody that binds activin type II A and B receptors to block activin and myostatin signaling. The candidate is in Phase II trials both as a standalone drug and in combination with the anti-#diabetes peptide #semaglutide.
#Wegovy #Mounjaro #ozempic #weightloss
https://bioprocessintl.com/bioprocess-insider/deal-making/lilly-going-bigger-on-obesity-with-versanis-buy/ -
Expect a renewed big push for obesity treatments. Lots of money riding on these therapies!
Eli #Lilly will pay up to $1.9 billion to acquire biotech #Versanis for it’s Phase II #Obesity candidate #Bimagrumab, a #MonoclonalAntibody that binds activin type II A and B receptors to block activin and myostatin signaling. The candidate is in Phase II trials both as a standalone drug and in combination with the anti-#diabetes peptide #semaglutide.
#Wegovy #Mounjaro #ozempic #weightloss
https://bioprocessintl.com/bioprocess-insider/deal-making/lilly-going-bigger-on-obesity-with-versanis-buy/ -
Expect a renewed big push for obesity treatments. Lots of money riding on these therapies!
Eli #Lilly will pay up to $1.9 billion to acquire biotech #Versanis for it’s Phase II #Obesity candidate #Bimagrumab, a #MonoclonalAntibody that binds activin type II A and B receptors to block activin and myostatin signaling. The candidate is in Phase II trials both as a standalone drug and in combination with the anti-#diabetes peptide #semaglutide.
#Wegovy #Mounjaro #ozempic #weightloss
https://bioprocessintl.com/bioprocess-insider/deal-making/lilly-going-bigger-on-obesity-with-versanis-buy/ -
Expect a renewed big push for obesity treatments. Lots of money riding on these therapies!
Eli #Lilly will pay up to $1.9 billion to acquire biotech #Versanis for it’s Phase II #Obesity candidate #Bimagrumab, a #MonoclonalAntibody that binds activin type II A and B receptors to block activin and myostatin signaling. The candidate is in Phase II trials both as a standalone drug and in combination with the anti-#diabetes peptide #semaglutide.
#Wegovy #Mounjaro #ozempic #weightloss
https://bioprocessintl.com/bioprocess-insider/deal-making/lilly-going-bigger-on-obesity-with-versanis-buy/ -
Expect a renewed big push for obesity treatments. Lots of money riding on these therapies!
Eli #Lilly will pay up to $1.9 billion to acquire biotech #Versanis for it’s Phase II #Obesity candidate #Bimagrumab, a #MonoclonalAntibody that binds activin type II A and B receptors to block activin and myostatin signaling. The candidate is in Phase II trials both as a standalone drug and in combination with the anti-#diabetes peptide #semaglutide.
#Wegovy #Mounjaro #ozempic #weightloss
https://bioprocessintl.com/bioprocess-insider/deal-making/lilly-going-bigger-on-obesity-with-versanis-buy/